Desmopressin acetate in cardiac surgery

A double-blind, randomized study

Barbara K. Temeck, Lisa C. Bachenheimer, Nevin M. Katz, Steven Scott Coughlin, Robert B. Wallace

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Use of desmopressin acetate (DDAVP) for patients having cardiac surgery is controversial. We did a double-blind, randomized study of 83 patients having cardiac operations at Georgetown University Hospital. The effect of DDAVP on bleeding as compared to placebo was evaluated by blood loss, replacement volume, and laboratory tests. There were no significant differences in baseline and intraoperative data between the DDAVP (n = 40) and placebo (n = 43) groups. Total drainage for the first 24 postoperative hours was 1,214 mL (±78) for the DDAVP group and 1,386 mL (± 116) for the placebo group (not significant). There were no significant differences in replacement therapy. In this study, administration of DDAVP did not decrease bleeding.

Original languageEnglish (US)
Pages (from-to)611-615
Number of pages5
JournalSouthern Medical Journal
Volume87
Issue number6
DOIs
StatePublished - Jan 1 1994
Externally publishedYes

Fingerprint

Deamino Arginine Vasopressin
Double-Blind Method
Thoracic Surgery
Placebos
Hemorrhage
Drainage

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Desmopressin acetate in cardiac surgery : A double-blind, randomized study. / Temeck, Barbara K.; Bachenheimer, Lisa C.; Katz, Nevin M.; Coughlin, Steven Scott; Wallace, Robert B.

In: Southern Medical Journal, Vol. 87, No. 6, 01.01.1994, p. 611-615.

Research output: Contribution to journalArticle

Temeck, Barbara K. ; Bachenheimer, Lisa C. ; Katz, Nevin M. ; Coughlin, Steven Scott ; Wallace, Robert B. / Desmopressin acetate in cardiac surgery : A double-blind, randomized study. In: Southern Medical Journal. 1994 ; Vol. 87, No. 6. pp. 611-615.
@article{55ac0b862779453cb263758c50914578,
title = "Desmopressin acetate in cardiac surgery: A double-blind, randomized study",
abstract = "Use of desmopressin acetate (DDAVP) for patients having cardiac surgery is controversial. We did a double-blind, randomized study of 83 patients having cardiac operations at Georgetown University Hospital. The effect of DDAVP on bleeding as compared to placebo was evaluated by blood loss, replacement volume, and laboratory tests. There were no significant differences in baseline and intraoperative data between the DDAVP (n = 40) and placebo (n = 43) groups. Total drainage for the first 24 postoperative hours was 1,214 mL (±78) for the DDAVP group and 1,386 mL (± 116) for the placebo group (not significant). There were no significant differences in replacement therapy. In this study, administration of DDAVP did not decrease bleeding.",
author = "Temeck, {Barbara K.} and Bachenheimer, {Lisa C.} and Katz, {Nevin M.} and Coughlin, {Steven Scott} and Wallace, {Robert B.}",
year = "1994",
month = "1",
day = "1",
doi = "10.1097/00007611-199406000-00006",
language = "English (US)",
volume = "87",
pages = "611--615",
journal = "Southern Medical Journal",
issn = "0038-4348",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Desmopressin acetate in cardiac surgery

T2 - A double-blind, randomized study

AU - Temeck, Barbara K.

AU - Bachenheimer, Lisa C.

AU - Katz, Nevin M.

AU - Coughlin, Steven Scott

AU - Wallace, Robert B.

PY - 1994/1/1

Y1 - 1994/1/1

N2 - Use of desmopressin acetate (DDAVP) for patients having cardiac surgery is controversial. We did a double-blind, randomized study of 83 patients having cardiac operations at Georgetown University Hospital. The effect of DDAVP on bleeding as compared to placebo was evaluated by blood loss, replacement volume, and laboratory tests. There were no significant differences in baseline and intraoperative data between the DDAVP (n = 40) and placebo (n = 43) groups. Total drainage for the first 24 postoperative hours was 1,214 mL (±78) for the DDAVP group and 1,386 mL (± 116) for the placebo group (not significant). There were no significant differences in replacement therapy. In this study, administration of DDAVP did not decrease bleeding.

AB - Use of desmopressin acetate (DDAVP) for patients having cardiac surgery is controversial. We did a double-blind, randomized study of 83 patients having cardiac operations at Georgetown University Hospital. The effect of DDAVP on bleeding as compared to placebo was evaluated by blood loss, replacement volume, and laboratory tests. There were no significant differences in baseline and intraoperative data between the DDAVP (n = 40) and placebo (n = 43) groups. Total drainage for the first 24 postoperative hours was 1,214 mL (±78) for the DDAVP group and 1,386 mL (± 116) for the placebo group (not significant). There were no significant differences in replacement therapy. In this study, administration of DDAVP did not decrease bleeding.

UR - http://www.scopus.com/inward/record.url?scp=0028240170&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028240170&partnerID=8YFLogxK

U2 - 10.1097/00007611-199406000-00006

DO - 10.1097/00007611-199406000-00006

M3 - Article

VL - 87

SP - 611

EP - 615

JO - Southern Medical Journal

JF - Southern Medical Journal

SN - 0038-4348

IS - 6

ER -